Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|May 4, 1999
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapyW A Breeman, L J Hofland, M de Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor sizeM de Jong, W A Breeman, B F Bernard, et al.
Nuclear Medicine and Biology|January 15, 1998
Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in ratsW A Breeman, M de Jong, B F Bernard, et al.
EJNMMI Research|January 22, 2016
Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotateHo Sze Chan, Mark W Konijnenberg, Erik de Blois, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1996
Studies on radiolabeled somatostatin analogues in rats and in patientsW A Breeman, W H Bakker, M De Jong, et al.
European Journal of Nuclear Medicine|February 1, 1993
Patients with a normal exercise thallium-201 myocardial scintigram: always a good prognosis?W P Oosterhuis, A Breeman, M G Niemeyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liverM de Jong, W H Bakker, W A Breeman, et al.
Pageof 7